Lidocaine plasters for postherpetic neuralgia?

Each year in the UK, about 1 in 2,500 people experiences neuropathic pain that is still present 3-6 months after acute herpes zoster (shingles). This condition, known as postherpetic neuralgia, is the most common complication of herpes zoster and can be chronic, intractable and distressing. Treatments used in an attempt to reduce postherpetic neuralgia include tricyclic antidepressants (e.g. amitriptyline--an unlicensed indication), antiepileptics (e.g. gabapentin) and opioid analgesics, as well as topical treatments such as capsaicin. However, such treatments may only provide partial pain relief, and tolerability can be a problem, particularly in older patients. Versatis (Grunenthal Ltd), a topical preparation of lidocaine formulated in a plaster, has recently been licensed for treating patients with postherpetic neuralgia. Does it offer useful benefit?
JournalDrug and therapeutics bulletin (Drug Ther Bull) Vol. 46 Issue 2 Pg. 14-6 (Feb 2008) ISSN: 0012-6543 [Print] England
PMID18256177 (Publication Type: Journal Article)
Chemical References
  • Anesthetics, Local
  • Lidocaine
  • Administration, Topical
  • Anesthetics, Local (administration & dosage)
  • Bandages
  • Humans
  • Lidocaine (administration & dosage)
  • Neuralgia, Postherpetic (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: